Stockreport

Supernus Announces FDA Approval of ONAPGO™ (apomorphine hydrochloride) for Parkinson's Disease [Yahoo! Finance]

Supernus Pharmaceuticals, Inc.  (SUPN) 
Last supernus pharmaceuticals, inc. earnings: 2/25 04:40 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.supernus.com
PDF Tue, February 4, 2025 at 3:00 PM GMT+1 13 min read In This Article SUPN Supernus Pharmaceuticals, Inc. ONAPGO is the first and only subcutaneous apomorphine i [Read more]